Plant Isoprenoids: A General Overview
Borderline personality disorder (BPD) was first described 75 years ago (Stern, 1938), but only became accepted in the classification of mental disorders decades later (American Psychiatric Association, 1980); but it was at that point that research on the disorder took off. Formal investigation of BPD also led to a reformulation of its nature, moving from a condition lying on a “border” between neurosis and psychosis to a personality disorder rooted in underlying traits but associated with prominent symptoms. Thus BPD emerges from complex and interactive biological and psychosocial risk factors (Crowell, Beauchaine, & Linehan, 2009; Paris, 2007). There is no single explanation for its cause, and risks are not the same in all patients. The pathways to BPD demonstrate equifinality, with different pathways capable of leading to the same outcome (Cicchetti & Rogosch, 2002).
Work in my group is supported by grants from Catalan (AGAUR 2009SGR-26), Spanish (DGI BIO2011-23680 and PIM2010IPO-00660), European (FP7 TiMet), and Ibero-American (CYTED 112RT0445-IBERCAROT) agencies.
- 1.Croteau R, Kutchan T, Lewis N (2000) Natural products (secondary metabolites). In: Buchanan B, Gruissem W, Jones R (eds) Biochemistry and molecular biology of plants. American Society of Plant Biologists, Rockville, MD, pp 1250–1268Google Scholar
- 16.Flores-Perez U, Perez-Gil J, Closa M, Wright LP, Botella-Pavia P, Phillips MA, Ferrer A, Gershenzon J, Rodriguez-Concepcion M (2010) PLEIOTROPIC REGULATORY LOCUS 1 (PRL1) integrates the regulation of sugar responses with isoprenoid metabolism in Arabidopsis. Mol Plant 3:101–112PubMedCrossRefGoogle Scholar
- 17.Rodríguez-Concepción M, Campos N, Ferrer A, Boronat A (2013) Biosynthesis of isoprenoid precursors in Arabidopsis. In: Bach TJ, Rohmer M (eds) Isoprenoid synthesis in plants and microorganisms: new concepts and experimental approaches. Springer, New York, pp 436–456Google Scholar